| Introduction Do you lack health insurance but make too much money to qualify for government assistance? Are your prescription co-payments so high that you can’t afford other basic necessities? Help may be available from pharmaceutical companies in the form of patient assistance programs (PAPs) and co-pay programs, not only for HIV medications, but also for hepatitis B and hepatitis C treatments. PROGRAMS FOR HIV Co-Pay Programs These programs offer assistance to people with private health insurance for the co-payments required to obtain HIV drugs at the pharmacy. Some companies offer co-pay assistance for all of their drugs, including non-HIV drugs. | Abbott | | Drugs covered: Kaletra, Norvir | | Contact Information: 800-441-4987, or go to the product websites (e.g. www.kaletra.com) | | Program Details: The Kaletra co-pay assistance covers the first $50 per prescription per month, plus $50 per prescription per month for other drugs in the regimen—up to $100 total for the other prescriptions. For the Norvir program, Abbott covers the first $50 of your co-payment, with no additional assistance for other drugs in the regimen. Currently, a person must reapply for the program each year. | | Boehringer Ingelheim | | Drugs covered: Viramune | | Contact Information: 877-411-8641 of viramunexr.com. | | Program Details: The co-pay assistance starts at the first dollar paid by the consumer. The program covers the first $100 per-month of your Viramune co-payment for all BI HIV products. The program does not cover Aptivus prescriptions. Currently, a person must reapply for the program each year. | | Bristol-Myers Squibb | | Drugs covered: Atripla, Reyataz, Sustiva, Videx and Zerit | | Contact Information: 888-281-8981 for Sustiva and Reyataz or 866-784-3431 for Atripla or go to the product websites (e.g. www.sustiva.com) | | Program Details: The program covers the first $200 per-month of your co-payment for all BMS HIV products. Currently, a person must reapply for the program each year. | | Genentech/Roche | | HIV Drugs covered: None | | Contact Information: None | | Program Details: No program, might cover co-pays through their patient assistance program. | | Gilead Sciences | | Drugs covered: Atripla, Complera, Emtriva, Stribild, Truvada, Viread | | Contact Information: 877-505-6986 for all five drugs, or go to product websites (e.g. www.truvada.com) | | Program Details: The program covers the first $200 per-month of your co-payment for Gilead HIV products. Currently, a person must reapply for the program each year. | | Janssen Therapeutics | | Drugs covered: Complera, Edurant, Intelence, Prezista | | Contact Information: 866-961-7169 for Edurant, Intelence or Prezista, or 877-505-6986 for Complera, or go to product websites (e.g. www.prezista.com) | | Program Details: After paying the first $5 of your co-payment, you can save up to $100 monthly for up to one year. Currently, you must reapply for the program each year. | | Merck & Co. | | Drugs covered: Isentress | | Contact Information: 866-350-9232 or www.isentress.com | | Program Details: The program covers the first $400 per-month of your co-payment for Merck HIV products. Currently, a person must reapply for the program each year. | Patient Assistance Programs and Welvista Programs for HIV Patient Assistance Programs (PAPs) offer free HIV drugs to people with low-incomes who do not qualify for any other insurance or assistance programs, such as Medicaid or AIDS Drug Assistance Programs (ADAPs). Different company programs have different eligibility criteria, notably incomes that do not exceed a certain percentage above the Federal Poverty Level (FPL). The 2012 FPL income for one individual is $11,170. It is adjusted based on family or household size. A complete table is at http://aspe.hhs.gov/poverty/12poverty.shtml. Unless otherwise stated, companies ask for verification of income, usually in the form of a federal income tax return. Companies also generally consider household income, meaning that a married couple that files joint taxes would be judged on their combined income. People who file individual income tax returns would only have their individual income considered. Always apply for an exception if told you are not eligible. A special program which is overseen by the Heinz Family Philanthropies, and managed by Welvista, a non-profit mail-order pharmacy based in South Carolina, has been initiated to make it easier for people on ADAP waiting lists to access their HIV medications from one location rather than having to access multiple industry PAPs to obtain their medications for different manufacturers. Thus far, Welvista is working with six HIV drug companies to provide HIV drugs for free to individuals on ADAP waiting lists. Please note:  | Some companies are using Welvista for ADAP waiting list patients. |  | Some companies are covering waiting list patients through their own PAPs. |  | Some companies are also covering ADAP disenrolled clients through their own PAP programs and some are not. |  | If an ADAP patient has been disenrolled because the state has lowered FPL eligibility, the drug company or Welvista FPL may also be too low to cover them. Check the individual company PAP criteria; and always apply for an exception if you are told you are not eligible. | It is also important to note that, as of September 12, 2012, people living with HIV and their health care providers can use a single application form to apply for patient assistance programs maintained by different pharmaceutical companies. Prior to the development of the common form, patients and their providers had to fill out different sets of paperwork to apply for assistance from each company–common for complicated, multi-drug regimens. This was a time-consuming and burdensome process. and the new streamlined application has the potential to provide faster, easier access to live-saving medications. To access the Common Patient Assistance Program Application (CPAPA), click here. | Abbott | | Drugs covered: Kaletra, Norvir | | Contact Information: 800-222-6885 or www.abbottpatientassistancefoundation.org | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). Abbott’s Patient Assistance Foundation covers people with incomes up to 500 percent of the FPL. Abbott does not request income verification and they only consider the income of the individual. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. Abbott currently participates in the Welvista program. | | Boehringer Ingelheim | | Drugs covered: Aptivus, Viramune | | Contact Information: 800-556-8317 or www.rxhope.com or www.pparx.org. | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. BI’s program covers people with incomes up to 500 percent of the FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. BI does not currently participate in the Welvista program. | | Bristol-Myers Squibb | | Drugs covered: Atripla, Reyataz, Sustiva, Videx and Zerit | | Contact Information: 888-477-2669 or www.pparx.org or go to product websites (e.g. www.sustiva.com). The Atripla PAP is handled separately at 866-290-4767 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. BMS’s program covers people with incomes up to 300 to 500 percent of the FPL, depending on the FPL criteria for each state’s ADAP program. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. BMS currently participates in the Welvista program. | | Genentech/Roche | | HIV Drugs covered: Fuzeon | | Contact Information: 877-757-6243 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). Genentech’s program covers people with incomes up to 950 percent of the FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. Genentech does not currently participate in the Welvista program. | | Gilead Sciences | | Drugs covered: Atripla, Complera, Emtriva, Stribild, Truvada, Viread | | Contact Information: 800-226-2056 or go to product websites (e.g. www.truvada.com). The Atripla PAP is handled separately at 866-290-4767 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). Gilead’s program covers people with incomes up to 500 percent of FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. Gilead currently participates in the Welvista program. | | Janssen Therapeutics | | Drugs covered: Edurant, Intelence, Prezista | | Contact Information: 800-652-6227 or Johnson & Johnson's Patient Assistance Foundation (www.jjpaf.org) | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). Janssen’s program covers people with incomes up to 200 percent of the FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. Tibotec currently participates in the Welvista program. | | Merck & Co. | | Drugs covered: Crixivan, Isentress | | Contact Information: 800-850-3430 or www.isentress.com | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). Merck’s program covers people with incomes up to 500 percent of the FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. Merck currently participates in the Welvista program. | | ViiV Healthcare | | Drugs covered: Combivir, Epivir, Epzicom, Lexiva, Rescriptor, Retrovir, Selzentry, Trizivir, Viracept and Ziagen | | Contact Information: 877-784-4842 or www.viivhealthcareforyou.com. | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels (FPL). ViiV’s program covers people with incomes up to 500 percent of the FPL. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. People initially denied coverage through the PAP should apply a second time and ask for a relevant exception. ViiV currently participates in the Welvista program. | PROGRAMS FOR VIRAL HEPATITIS Co-Pay Programs These programs offer assistance to people with private insurance for the co-payments required to obtain HBV and/or HCV drugs at the pharmacy. Hepatitis B Virus (HBV) | Bristol-Myers Squibb | | Drugs covered: Baraclude | | Contact Information: 866-715-9050. Ask the operator to speak to someone about the Baraclude Co-pay Benefits Program and ask for a card to be mailed to you. | | Program Details: The co-pay assistance starts after the first $20 of a co-pay has been paid by the consumer. The co-pay assistance then covers up to $100 dollars per prescription per month. Currently the program runs for six months. | | Gilead Sciences | | Drugs covered: Hepsera, Viread | | Contact Information: 888-358-0398 | | Program Details: The co-pay assistance starts after the first $50 of a co-pay has been paid by the consumer. The co-pay assistance then covers up to $200 dollars per prescription per month. There is also a program for people who pay for their prescription in full that covers the first $200 per month. | | GlaxoSmithKline | | Drugs covered: Epivir | | Contact Information: 888-825-5249 or www.mysupportcard.com | | Program Details: The co-pay assistance starts at the first dollar paid by the consumer. The co-pay assistance then covers up to $100 dollars per prescription per month and includes non-HBV drugs. | Hepatitis C Virus (HCV) | Merck & Co. | | Drugs covered: Victrelis | | Contact Information: 866-363-6379 or www.victrelis.com | | Program Details: People can print out a card at www.victrelis.com, which entitles them to receive up to $200 savings on their copayment for each Victrelis prescription, on up to 12 prescriptions (which would be a full 44 weeks of treatment for those who need it for that duration). | | Vertex Pharmaceuticals | | Drugs covered: Incivek | | Contact Information: 855-837-8394 or www.incivek.com | | Program Details: Vertex will cover co-pay or co-insurance costs up to 20 percent of the total cost of Incevik for people who have private insurance plans that cover Incevik. | PAP Programs These programs offer free HBV and HCV drugs to people with low-incomes who do not qualify for any other insurance or assistance programs, such as Medicaid or Medicare. Different company programs have different eligibility criteria based on the Federal Poverty Level (FPL). The 2010 FPL income for an individual is $10,830 annual income. It is adjusted based on family or household size. 200% FPL is $21,660 annual income for an individual and 300% is $32,490 annual income. A complete table is available at http://aspe.hhs.gov/poverty/10poverty.shtml. Unless otherwise stated, companies ask for verification of income, usually in the form of a federal income tax return. Companies also generally consider household income, meaning that a married couple that files joint taxes would be judged on their combined income. People who file individual income tax returns would only have their individual income considered. Always apply for an exception if told you are not eligible. Hepatitis B Virus (HBV) | Bristol-Myers Squibb | | Drugs covered: Baraclude | | Contact Information: 800-736-0003 or visit www.bmspaf.org | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established FPL percentages. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | | Gilead Sciences | | Drugs covered: Hepsera, Viread | | Contact Information: 800-226-2056 or visit www.hepsera.com | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established FPL percentages. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | | GlaxoSmithKline | | Drugs covered: Epivir | | Contact Information: 866-475-3678 or www.gskforyou.com | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established FPL percentages. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | Hepatitis C Virus (HCV) | Amgen | | Drugs covered: Epogen* | | Contact Information: 800-272-9376 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down.. | | *Epogen is not a treatment for HCV, but it is a treatment for anemia, which is a side effect commonly caused by HCV treatment. | | | Genentech/Roche | | Drugs covered: Pegasys and Copegus | | Contact Information: 888-941-3331 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | | Merck & Co. | | Drugs covered: Pegintron, Rebetol and Victrelis | | Contact Information: 866-363-6379 | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | | Vertex Pharmaceuticals | | Drugs covered: Incivek | | Contact Information: 855-837-8394 or www.incivek.com | | Program Details: The PAP is for people who do not qualify for other assistance or health insurance programs and is limited by income. Most programs have limits based on the total household income compared to established federal poverty levels. The Incivek PAP helps people whose household income is less than $100,000 per year. Generally, programs will accept appeals for special circumstances if a person does not initially qualify and is turned down. | The above is based on a document originally produced by the Fair Pricing Coalition, an ad hoc group of activists who advocate with the pharmaceutical industry regarding the price and patient access to HIV and viral hepatitis drugs. For more information, please visit www.fairpricingcoalition.org. |